THE USE OF PHARMACEUTICAL COMPOSITIONS COMPRISING TRIGLYCERIDES WITH SEVEN - CARBON FATTY ACID IN THE PREPARATION OF MEDICAMENTS FOR THE TREATMENT OF FATTY ACID METABOLIC DEFECT

摘要

A seven-carbon fatty acid, preferably n-heptanoic acid, has been identified as an excellent energy source for patients suffering from inherited metabolic disorders or acquired metabolic derangements, especially defects in long-chain fatty acid metabolism. A seven-carbon fatty acid can also be provided in a nutritional supplement for patients who need an increase in the energy production derived from fatty acid metabolism.